Coronavirus Covid-19 Hub

Practical guidance for the management of adults with Immune Thrombocytopenia during the COVID-19 pandemic Updated January 2021

Practical guidance for the management of adults with Immune Thrombocytopenia during the COVID-19 pandemic

Updated January 2021

Pavord S, Thachil J, Hunt B, Murphy M, Lowe G, Laffan M, Makris M, Newland A, Provan D, Grainger J, Hill Q.

This document aims to provide practical guidance for the assessment and management of patients with Immune Thrombocytopenia (ITP) during the COVID-19 pandemic. The intention is to support clinicians and, although recommendations have been provided, it is not a formal guideline. Nor is there sufficient evidence base to conclude that alternative approaches to treatment are incorrect. Instead, it is a consensus written by clinicians with an interest in ITP or coagulation disorders and reviewed by members of the UK ITP forum.

Guidance on management of ITP during the covid pandemic updated 20210104 (PDF Version)